Save Over $1,000 Off an eBike for a Limited Time

Paris-based Exeliom Biosciences completes final close of €24 million Series A to further progress its microbiome-based inmunotherapy

July 3, 2023

Exeliom Biosciences, a clinical-stage biopharmaceutical company specialized in the development of microbiome-based immunotherapies with a mission to bring innovation to the treatment of inflammatory bowel diseases, cancer, and infectious diseases, announced today the completion of its €24 million Series A to progress the clinical development of its therapeutic pipeline, including several clinical

Save Over $1,000 Off an eBike for a Limited Time

46% of All Google Searches Have to Do With Location, One Report Says — and Purchases Often Follow. Here's How to Boost Your Business' Visibility Locally.

Paris-based Exeliom Biosciences completes final close of €24 million Series A to further progress its microbiome-based inmunotherapy